Crown Bioscience Named Fierce CRO Award Winner for Excellence in Global Operations
Crown Bioscience Named Fierce CRO Award Winner for Excellence in Global Operations
Share
The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations, recognizing CROs demonstrating outstanding performance, innovation, and leadership in delivering high-quality research and development services. The awards emphasize the critical role CROs play in advancing life sciences research and improving patient outcomes.
John Gu, Chief Executive Officer of Crown Bioscience, stated, "Winning this award for Excellence in Global Operations is a proud moment for Crown Bioscience and a meaningful recognition of the outstanding work delivered by our global operations team. Alongside our 2024 Excellence in Client Services and Partnership Award, these accolades highlight our unwavering commitment to serving clients with excellence and our contribution to discovering innovative new medicines."
Fierce CRO Award finalists and winners are evaluated based on Innovation and Impact, Measurable Outcomes, Sustainability and Scalability, and Ethical and Regulatory Adherence. Winners are featured in the Fierce CRO Report. Click here to read the report: https://www.fiercebiotech.com/cro/excellence-global-operations
About Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world's largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Metaplanet Picks Up Additional 2,205 BTC, Holdings Now Cross 15,555 Bitcoin
Japan-based Metaplanet has acquired an additional 2,205 bitcoin (BTC) as part of its ongoing Bitcoin Treasury strategy, bringing its total holdings to 15,555 BTC per a new disclosure on Monday. The latest purchase was made at an average price of 15.64 million yen per bitcoin, totaling approximately 34.49 billion yen ($213 million). That pushes Metaplanet's aggregate BTC investment to 225.82 billion yen ($1.38 billion), with a blended average purchase price of 14.52 million yen per BTC. Metaplanet utilizes a custom metric, called BTC Yield, to track shareholder value in relation to dilution. For the quarter ending June 30, the company reported a BTC Yield of 95.6%, following a 309.8% yield in the previous quarter. BTC Yield reflects the percentage change in bitcoin holdings per fully diluted share, isolating the effect of accretive treasury actions. The firm also tracks BTC Gain and BTC Yen Gain — which translate that yield into hypothetical BTC increases and yen-denominated performance, respectively — to give investors a clearer sense of overall in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
an hour ago
- Wall Street Journal
Oil Slips on Larger OPEC+ Output Hike
Oil prices slipped after the Organization of the Petroleum Exporting Countries and its allies agreed to a larger-than-expected production hike for the fourth straight month, fueling concerns about a global supply glut at a time when the demand outlook looks uncertain. Eight OPEC+ countries said they will increase production by 548,000 barrels a day in August–the equivalent of four monthly increments and above the 411,000 barrels a day forecast by analysts.
Yahoo
an hour ago
- Yahoo
Factbox-How China tightened its grip over its rare earth sector
(Reuters) -When China restricted rare earth exports to Japan in 2010 during a diplomatic spat, a wild west domestic industry undermined Beijing with rampant smuggling. In a sharp shift that reflects how China has massively tightened control over the sector since then, when it imposed new restrictions in April this year, automakers worldwide faced shortages within two months leading some to pause production. Through consolidation and quotas, Beijing has turned a once-unruly sector, responsible for 90% of rare earth processing capacity, into a powerful source of diplomatic leverage. Here is a summary of how the world's number one rare earth producer has tightened its grip over the industry. CONSOLIDATION When China began its crackdown on the sector some fifteen years ago, there were hundreds of miners and processors. By 2013 ten producers controlled almost all mining. Today, there are just two state-owned giants: China Rare Earth Group and China Northern Rare Earth Group High-Tech. The decade-plus process of consolidation gave Beijing greater oversight while also curbing some of the environmental damage caused by illegal and reckless mining, according to David Abraham, affiliate professor at Boise State University, in Idaho. In the past an illegal supply chain of rogue miners delivered ore to unauthorised separation facilities, with the finished products then disguised and shipped abroad. Roughly 40,000 metric tons of rare earth oxides were estimated to have been smuggled overseas in 2014, half as much again as official exports. Magnet makers, however, have not consolidated in the same way as the upstream mining and refining sector, with dozens of producers and processors across China, including JL Mag Rare-Earth and Ningbo Yunsheng. However, China introduced a tracking system for its rare earth magnet sector from June, requiring companies to submit information including customer details and transaction volumes. It ultimately aims to track the entire supply chain. QUOTAS In conjunction with consolidation, China has also used its production quota system, introduced in 2006, to control supply. The quotas cover mining, smelting and separation. Typically issued twice a year, they are widely monitored as a barometer for global supply. Beijing has gradually narrowed access to quotas and in 2024, only the two state-owned groups were eligible, compared to six previously. China has dramatically slowed down supply growth from 2024 when the total mining output quota grew only 5.9% year-on-year, versus an annual rise of 21.4% in 2023. Analysts and traders expect mining output quotas this year to either stay flat or rise by up to 5% from 2024's level. Beijing also restricts exports of technology. The tools and means to extract and separate rare earths have long been banned. In late 2023 it extended that ban to the technology used to make rare earth magnets.
